These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4172651)

  • 1. Effect of oral contraceptive agents on platelets and plasma-phospholipids.
    Bolton CH; Hampton JR; Mitchell JR
    Lancet; 1968 Jun; 1(7556):1336-41. PubMed ID: 4172651
    [No Abstract]   [Full Text] [Related]  

  • 2. Nature of the transferable factor which causes abnormal platelet behaviour in vascular disease.
    Bolton CH; Hampton JR; Mitchell JR
    Lancet; 1967 Nov; 2(7526):1101-5. PubMed ID: 4168551
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet behaviour and plasma phospholipids in multiple sclerosis.
    Bolton CH; Hampton JR; Phillipson OT
    Lancet; 1968 Jan; 1(7534):99-104. PubMed ID: 4169644
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of phospholipids on platelet electrophoretic mobility.
    Hampton JR; Bolton CH
    J Atheroscler Res; 1969; 9(2):131-9. PubMed ID: 5770396
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet aggregation during oral contraception.
    Poller L; Priest CM; Thomson JM
    Br Med J; 1969 Nov; 4(5678):273-4. PubMed ID: 4186656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma phospholipids and platelet stickiness in multiple sclerosis.
    Lancet; 1968 Jan; 1(7534):134-5. PubMed ID: 4169610
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the metabolic effects of chlormadinone acetate and conventional contraceptive steroids in man.
    Beck P
    J Clin Endocrinol Metab; 1970 Jun; 30(6):785-91. PubMed ID: 4192202
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of aggregating agents on platelet electrophoretic mobility.
    Hampton JR; Mitchell JR
    Thromb Diath Haemorrh Suppl; 1967; 26():69-70. PubMed ID: 6064878
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose continuous chlormadinone acetate as an oral contraceptive. A clinical trial.
    Howard G; Blair M; Elstein M; Morris NF
    Lancet; 1969 Jul; 2(7610):24-6. PubMed ID: 4182794
    [No Abstract]   [Full Text] [Related]  

  • 10. Contraceptive treatment with chlormadinone and its effect on the endometrium. A histological investigation.
    Kühne D; Seidl S; Göretzlehner G
    Endokrinologie; 1972 May; 59(3):295-306. PubMed ID: 4116092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alteration of surface charge characteristics of the vascular system by oral contraceptive steroids.
    Srinivasan S; Solash J; Redner A; Moser C; Farhangian D; Lucas TR; Ateyeh E; McCool CT+MACCOOL CT; Weber D; Puvan SI; Jones JR; Sawyer PN
    Contraception; 1974 Mar; 9(3):291-303. PubMed ID: 4442278
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenosine phosphate and platelet mobility.
    Betts JJ; Betts JP; Nicholson JT
    Lancet; 1968 Jul; 2(7560):172. PubMed ID: 4173294
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood clotting and platelet aggregation during oral progestogen contraception: a follow-up study.
    Poller L; Thomson JM; Thomas W; Wray C
    Br Med J; 1971 Mar; 1(5751):705-7. PubMed ID: 4101481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma proteins after continuous, oral use of a progestogen--chloromadionone acetate--as a contraceptive.
    Laurell CB; Kullander S; Thorell J
    Scand J Clin Lab Invest; 1969 Dec; 24(4):387-9. PubMed ID: 4192239
    [No Abstract]   [Full Text] [Related]  

  • 16. [1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics].
    Gödel E; Gödel B
    Dtsch Gesundheitsw; 1970 Apr; 25(14):627-31. PubMed ID: 4098543
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet adhesiveness, aggregation and fibrinolysis after the oral administration of the contraceptive "Lyndiol".
    Farbiszewski R; Kurowska T
    Thromb Diath Haemorrh; 1970 Oct; 24(1):304-7. PubMed ID: 5483970
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipid metabolism in women ingesting gestagens as contraceptives].
    Pisarek-Miedzińska D; Roszkowski I; Firek A
    Ginekol Pol; 1972; 43(12):1407-19. PubMed ID: 4119343
    [No Abstract]   [Full Text] [Related]  

  • 19. [Side effects of the oral contraceptive Ovosiston on the blood coagulation system].
    Carol W; Klinger G; Hempel E; Starker K; Quent P
    Zentralbl Gynakol; 1970 Dec; 92(50):1641-50. PubMed ID: 4099364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modification of the thrombocyte function using hormonal contraception. 1. Thrombocyte count, thrombocyte propagation and platelet aggregation under hormonal contraception].
    Traub RF; Brandt M; Hofmann KD
    Zentralbl Gynakol; 1976; 98(3):161-5. PubMed ID: 61668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.